| Period | Weighting | Quarter | ||||||
|---|---|---|---|---|---|---|---|---|
| Company | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
| Cormorant Asset Management, LP | 6 | 6 | 0.02% | 0.15% | 0.31% | Q1 2014 | Q2 2015 | 6 |
| MORGAN STANLEY | 6 | 6 | 0.00% | 0.00% | 0.00% | Q1 2014 | Q2 2015 | 6 |
| SABBY MANAGEMENT, LLC | 4 | 4 | 0.08% | 0.18% | 0.24% | Q1 2014 | Q4 2014 | 4 |
| Tower Research Capital LLC (TRC) | 4 | 4 | 0.00% | 0.00% | 0.00% | Q1 2014 | Q4 2014 | 4 |
| Baker Brothers Advisors | 4 | 4 | 0.03% | 0.05% | 0.06% | Q1 2014 | Q4 2014 | 4 |
| CITIGROUP INC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2014 | Q1 2015 | 4 |
| Broadfin Capital, LLC | 4 | 4 | 0.20% | 0.27% | 0.30% | Q1 2014 | Q4 2014 | 4 |
| DAFNA Capital Management LLC | 4 | 4 | 0.17% | 0.24% | 0.27% | Q1 2014 | Q4 2014 | 4 |
| FRANKLIN RESOURCES INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2014 | Q4 2014 | 3 |
| HighTower Advisors, LLC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q2 2014 | Q4 2014 | 3 |
| Citadel Advisors | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q2 2015 | 2 |
| UBS AG | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2014 | Q2 2014 | 2 |
| PRELUDE CAPITAL MANAGEMENT, LLC | 2 | 2 | 0.00% | 0.00% | 0.00% | Q2 2014 | Q3 2014 | 2 |
| Knoll Capital Management, LLC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q1 2014 | Q2 2014 | 2 |
| UBS Group AG | 2 | 2 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q2 2015 | 2 |
| AMERICAN INTERNATIONAL GROUP, INC. | 1 | 1 | 0.00% | 0.00% | 0.00% | Q2 2015 | Q2 2015 | 1 |
| WELLS FARGO & COMPANY/MN | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q1 2015 | 1 |
| Ground Swell Capital, LLC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q2 2014 | 1 |
| Sio Capital Management, LLC | 1 | 1 | 0.69% | 0.69% | 0.69% | Q4 2014 | Q4 2014 | 1 |
| Virtu KCG Holdings LLC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q1 2015 | Q1 2015 | 1 |
External links
This page lists all the filers that currently own CELSUS THERAPEUTICS PLC or have owned CELSUS THERAPEUTICS PLC in the past.